Neuroscience
Settling in in my coffeehouse for a reading of an interesting new publication by Dr. Brian Brooks and his colleagues on the topic of "Minimizing Misdiagnosis: Psychometric Criteria for Possible or Probable Memory Impairment." The authors seek to develop new psychometric criteria for identification of memory problems in older individuals. This has both clinical and research implications; my primary interest at this time is the accuracy of such identification for including or excluding individuals in clinical trials that test potential drug treatments for Alzheimer's and related dementias.
- Neuropsychology Abstract Of The Day: Diagnostic Value Of Subjective Complaints
Understanding the relation between subjective complaints and objective performance findings is always a crucial factor in clinical assessment. It is a source of debate by clinicians and researchers and a literature has developed examining the issues that...
- Neuropsychology Abstract Of The Day: Aging And Mci Screening
Today's recommended read deals with an important neuropsychological assessment issue in the domain of aging and the potential to identify the presence of cognitive problems that might (emphasis on "might" - such findings in a screen are not definitive)...
- Neuropsychology Abstract Of The Day: Mild Cognitive Impairment (mci)
Bondi MW, Jak AJ, Delano-Wood L, Jacobson MW, Delis DC, & Salmon DP. Neuropsychological Contributions to the Early Identification of Alzheimer's Disease. Neuropsychological Review. 2008 Mar 18. A wealth of evidence demonstrates that a prodromal period...
- Abstract Of The Day: Olfactory Functioning
Wilson RS, Arnold SE, Tang Y, & Bennett DA. Odor identification and decline in different cognitive domains in old age. Neuroepidemiology. 2006; 26(2): 61-67. Rush Alzheimer's Disease Center, Rush Institute for Healthy Aging, and Department of Neurological...
- Reminyl (galantamine Hydrobromide) (continued)
Safety Concerns Reported on J.& J. Alzheimer's Drug By ANDREW POLLACK New York Times Published: January 22, 2005 Regulators are reviewing the safety of the Alzheimer's disease drug Reminyl after data from two clinical trials indicated...
Neuroscience
Identification of Possible or Probable Memory Impairment
Settling in in my coffeehouse for a reading of an interesting new publication by Dr. Brian Brooks and his colleagues on the topic of "Minimizing Misdiagnosis: Psychometric Criteria for Possible or Probable Memory Impairment." The authors seek to develop new psychometric criteria for identification of memory problems in older individuals. This has both clinical and research implications; my primary interest at this time is the accuracy of such identification for including or excluding individuals in clinical trials that test potential drug treatments for Alzheimer's and related dementias.
- Neuropsychology Abstract Of The Day: Diagnostic Value Of Subjective Complaints
Understanding the relation between subjective complaints and objective performance findings is always a crucial factor in clinical assessment. It is a source of debate by clinicians and researchers and a literature has developed examining the issues that...
- Neuropsychology Abstract Of The Day: Aging And Mci Screening
Today's recommended read deals with an important neuropsychological assessment issue in the domain of aging and the potential to identify the presence of cognitive problems that might (emphasis on "might" - such findings in a screen are not definitive)...
- Neuropsychology Abstract Of The Day: Mild Cognitive Impairment (mci)
Bondi MW, Jak AJ, Delano-Wood L, Jacobson MW, Delis DC, & Salmon DP. Neuropsychological Contributions to the Early Identification of Alzheimer's Disease. Neuropsychological Review. 2008 Mar 18. A wealth of evidence demonstrates that a prodromal period...
- Abstract Of The Day: Olfactory Functioning
Wilson RS, Arnold SE, Tang Y, & Bennett DA. Odor identification and decline in different cognitive domains in old age. Neuroepidemiology. 2006; 26(2): 61-67. Rush Alzheimer's Disease Center, Rush Institute for Healthy Aging, and Department of Neurological...
- Reminyl (galantamine Hydrobromide) (continued)
Safety Concerns Reported on J.& J. Alzheimer's Drug By ANDREW POLLACK New York Times Published: January 22, 2005 Regulators are reviewing the safety of the Alzheimer's disease drug Reminyl after data from two clinical trials indicated...